actos bladder cancer lawsuit

Actos Bladder Cancer Award

$2 Million Awarded by Jury in Actos Bladder Cancer Lawsuit

A woman who required multiple surgeries to have her bladder cancer removed has been awarded more than $2 million for her Actos injuries and medical bills.

A Philadelphia jury last week awarded more than $2 million to a woman who was diagnosed with bladder cancer after using the controversial diabetes drug, Actos. Frances Wisniewski filed the Actos lawsuit against Takeda Pharmaceuticals, alleging that the drug company failed to provide adequate warnings for consumers and medical professionals about the risk of bladder cancer side effects from Actos. If you took the diabetes drug Actos in the past, and you have since been diagnosed with bladder cancer, contact an experienced Actos lawyer today to discuss your legal options. You may have grounds to file an Actos lawsuit against Takeda Pharmaceuticals, in order to pursue financial compensation for your losses.

Lawsuits Over Actos Bladder Cancer

Frances Wisniewski’s Actos bladder cancer claim joins several thousand lawsuits currently pending in courts across the country, all of which involve similar allegations that side effects of the diabetes drug caused users to develop bladder cancer after long-term use. In her complaint, Wisniewski claimed that, because of Actos, she required two surgeries in 2007 and 2008 to remove her bladder cancer. During the trial, Takeda attempted to blame Wisniewski’s bladder cancer on her 30 years of smoking, but the jury ultimately awarded Wisniewski $2,050,000 in damages following just five hours of deliberation.

Potential Side Effects of Actos

Actos (pioglitazone) is a diabetes drug that belongs to a class of medications called thiazolidinediones and is manfuctured by drug company Takeda Pharmaceuticals. Actos is commonly prescribed to lower blood glucose levels in patients with Type 2 diabetes, which it does by increasing the sensitivity of muscle, fat and liver cells to insulin, allowing the cells to remove glucose from the blood more effectively. Actos was approved by the U.S. Food and Drug Administration (FDA) in 1999, and has since become one of the most widely-used diabetes drugs in the United States. However, a growing body of research has identified the use of Actos for diabetes as a risk factor for the development of bladder cancer.

Contact a Skilled Actos Lawyer for Help

As more information about the risk of bladder cancer from Actos comes to light, a growing number of former Actos users are filing complaints against Takeda for bladder cancer and other complications they have suffered since taking the medication. If you believe you have been adversely affected by side effects of Actos, our consumer advocates at the Leading Justice can help. We are dedicated to protecting the rights of consumers harmed by allegedly dangerous pharmaceutical drugs, and can help put you in touch with a knowledgeable attorney who has experience handling Actos bladder cancer claims.

Scroll to Top